Complete Filing Data
SUTRO BIOPHARMA, INC. reported Net Income Loss of -$191.09 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SUTRO BIOPHARMA, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$191.1M | -$227.5M | -$106.8M | -$119.2M | -$105.5M | -$32.1M | -$119.2M | -$35.3M | -$19.7M | $1.7M |
| Revenue * | $102.5M | $62.0M | $153.7M | $67.8M | $61.9M | $42.7M | $42.7M | $38.4M | $51.7M | $59.7M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$20.0K | $18.0K | $639.0K | -$304.0K | -$443.0K | -$36.0K | $212.0K | -$47.0K | $17.0K | $34.0K |
| Research And Development Expense | $166.4M | $252.0M | $180.4M | $137.2M | $104.4M | $77.0M | $65.6M | $54.3M | $54.6M | $43.6M |
| Operating Income Loss | -$158.4M | -$238.5M | -$89.3M | -$128.9M | -$98.5M | -$71.1M | -$55.5M | -$37.2M | -$19.3M | $1.4M |
| Operating Expenses | $260.9M | $300.5M | $243.0M | $196.7M | $160.4M | $113.8M | $98.2M | $75.6M | $71.0M | $58.4M |
| Investment Income Nonoperating | $9.3M | $18.6M | $14.5M | $3.5M | $577.0K | $1.5M | $4.1M | $1.6M | $273.0K | $251.0K |
| General And Administrative Expense | $41.0M | $48.5M | $62.6M | $59.5M | $56.0M | $36.8M | $32.6M | $21.4M | $16.4M | $14.8M |
| Comprehensive Income Net Of Tax | -$191.1M | -$227.4M | -$106.2M | -$119.5M | -$106.0M | -$32.2M | -$55.5M | -$35.4M | -$19.7M | $1.7M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$191.2M | -$225.1M | -$88.6M | -$116.7M | -$105.5M | -$32.0M | ||||
| Revenue From Related Parties | $0.00 | $2.8M | $22.5M | $19.0M | $44.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$56.9M | -$11.5M | -$76.0M | -$48.8M | -$48.0M | -$58.2M | -$49.3M | -$38.5M | -$50.1M | -$19.5M | -$26.0M | -$39.1M | -$30.9M | -$6.2M | -$30.4M | -$59.5M | $17.1M | $29.9M | -$19.6M | -$14.8M | -$12.9M | -$13.8M | -$14.3M | -$1.5M | -$10.2M | -$11.5M | -$12.0M | -$15.3M | -$1.4M | -$1.8M | -$1.1M |
| Revenue * | $9.7M | $63.7M | $17.4M | $8.5M | $25.7M | $13.0M | $16.9M | $10.4M | $12.7M | $25.1M | $28.1M | $5.9M | $8.5M | $28.0M | $14.7M | $8.3M | $17.8M | $9.5M | $7.2M | $11.3M | $12.3M | $10.5M | $8.6M | $19.1M | $7.8M | $5.7M | $5.8M | $4.0M | $17.5M | $15.4M | $14.8M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $46.0K | -$4.0K | -$48.0K | $269.0K | -$50.0K | -$134.0K | -$9.0K | $123.0K | $511.0K | $20.0K | -$204.0K | -$838.0K | $15.0K | -$45.0K | -$129.0K | -$161.0K | $370.0K | -$137.0K | $10.0K | $157.0K | $103.0K | -$27.0K | $0.00 | $0.00 | $5.0K | ||||||
| Research And Development Expense | $39.9M | $38.3M | $51.6M | $62.1M | $62.0M | $56.9M | $45.7M | $41.6M | $39.4M | $31.7M | $32.3M | $30.0M | $26.6M | $25.3M | $22.6M | $19.4M | $17.2M | $17.6M | $16.9M | $16.1M | $15.2M | $12.6M | $13.8M | $13.1M | $13.7M | ||||||
| Operating Income Loss | -$48.5M | -$3.3M | -$68.5M | -$67.9M | -$48.7M | -$56.6M | -$44.0M | -$46.2M | -$42.2M | -$21.2M | -$19.4M | -$39.1M | -$34.7M | -$9.8M | -$19.0M | -$10.6M | -$16.4M | -$19.2M | -$12.7M | -$13.7M | -$14.3M | -$10.2M | -$12.1M | -$11.7M | -$1.1M | ||||||
| Operating Expenses | $58.2M | $67.1M | $85.9M | $76.4M | $74.4M | $69.6M | $60.9M | $56.6M | $54.9M | $46.4M | $47.5M | $45.0M | $43.2M | $37.9M | $33.7M | $28.4M | $25.9M | $26.3M | $25.0M | $24.2M | $22.9M | $18.0M | $17.8M | $17.5M | $18.6M | ||||||
| Investment Income Nonoperating | $2.0M | $2.5M | $3.2M | $4.9M | $4.9M | $4.1M | $4.6M | $2.8M | $2.6M | $1.0M | $197.0K | $116.0K | $109.0K | $175.0K | $197.0K | $295.0K | $384.0K | $641.0K | $964.0K | $1.1M | $1.2M | $403.0K | $40.0K | $40.0K | $62.0K | ||||||
| General And Administrative Expense | $8.7M | $10.3M | $13.3M | $14.3M | $12.4M | $12.7M | $15.3M | $15.0M | $15.5M | $14.6M | $15.1M | $15.0M | $16.6M | $12.5M | $11.1M | $9.1M | $8.6M | $8.7M | $8.1M | $8.1M | $7.7M | $5.4M | $4.0M | $4.4M | $4.9M | ||||||
| Comprehensive Income Net Of Tax | -$56.8M | -$11.5M | -$76.0M | -$48.5M | -$48.1M | -$58.3M | -$49.3M | -$38.4M | -$49.5M | -$19.5M | -$26.2M | -$39.9M | -$30.9M | -$6.2M | -$30.5M | $17.0M | $30.2M | -$19.7M | -$12.9M | -$13.6M | -$14.1M | -$10.3M | -$11.5M | -$12.0M | -$1.4M | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$56.9M | -$11.5M | -$48.8M | -$48.0M | -$58.2M | -$47.4M | -$38.4M | -$49.7M | -$19.5M | -$23.5M | -$39.1M | -$30.9M | -$6.2M | ||||||||||||||||||
| Revenue From Related Parties | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.8M | $6.3M | $5.5M | $4.9M | $6.1M | $3.7M | $4.1M | $15.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$132.5M | $44.6M | $149.6M | $217.0M | $252.6M | $332.0M | $97.8M | $131.5M | -$109.0M | -$90.9M | -$93.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $59.0M | $191.2M | $70.1M | $48.1M | $31.3M | $207.0M | $5.0M | $125.3M | $22.0M | $11.9M | |
| Restricted Cash Noncurrent | $858.0K | $858.0K | $872.0K | $872.0K | $872.0K | $872.0K | $15.0K | $15.0K | $15.0K | $275.0K | |
| Cash And Cash Equivalents At Carrying Value | $58.1M | $190.3M | $69.3M | $47.3M | $30.4M | $206.2M | $5.0M | $125.3M | $22.0M | $11.6M | |
| Accretion Amortization Of Discounts And Premiums Investments | $3.4M | $9.7M | $9.1M | $364.0K | -$2.8M | $490.0K | $1.5M | $527.0K | -$106.0K | -$168.0K | |
| Equity Securities Fv Ni Unrealized Gain Loss | $0.00 | $0.00 | $9.9M | $12.1M | -$4.5M | $41.5M | |||||
| Retained Earnings Accumulated Deficit | -$978.0M | -$786.9M | -$559.4M | -$452.6M | -$333.4M | -$227.9M | -$195.7M | -$150.3M | -$115.0M | ||
| Property Plant And Equipment Net | $10.6M | $18.2M | $21.9M | $24.6M | $22.6M | $12.9M | $9.6M | $10.9M | $14.0M | ||
| Prepaid Expense And Other Assets Current | $5.5M | $17.8M | $9.8M | $11.7M | $8.1M | $4.5M | $4.4M | $3.0M | $2.0M | ||
| Other Assets Noncurrent | $495.0K | $7.2M | $3.6M | $1.9M | $1.7M | $2.1M | $2.5M | $2.2M | $1.1M | ||
| Liabilities Current | $75.1M | $131.9M | $93.7M | $66.5M | $41.7M | $29.6M | $33.0M | $36.4M | $32.0M | ||
| Liabilities And Stockholders Equity | $173.8M | $387.2M | $470.7M | $406.9M | $341.4M | $394.1M | $156.4M | $223.1M | $40.8M | ||
| Liabilities | $306.3M | $342.6M | $321.1M | $189.9M | $88.8M | $62.1M | $58.6M | $91.6M | $47.3M | ||
| Assets Current | $150.9M | $343.3M | $421.5M | $353.2M | $218.5M | $378.2M | $128.6M | $209.9M | $25.6M | ||
| Assets | $173.8M | $387.2M | $470.7M | $406.9M | $341.4M | $394.1M | $156.4M | $223.1M | $40.8M | ||
| Additional Paid In Capital Common Stock | $845.5M | $831.4M | $709.0M | $670.2M | $586.2M | $559.7M | $293.3M | $281.9M | $6.2M | ||
| Accrued Liabilities Current | $14.6M | $12.9M | $14.7M | $13.1M | $11.4M | $8.8M | $6.0M | $6.2M | $3.6M | ||
| Accounts Receivable Net Current | $4.0M | $8.6M | $36.1M | $7.1M | $12.5M | $5.6M | $6.3M | $2.5M | $1.6M | ||
| Accounts Payable Current | $7.6M | $10.5M | $9.4M | $4.8M | $6.0M | $5.5M | $5.6M | $3.1M | $2.9M | ||
| Marketable Securities Current | $83.3M | $126.6M | $264.4M | $255.1M | $130.3M | $120.3M | $112.9M | $79.2M | |||
| Contract With Customer Liability Current | $10.6M | $69.8M | $20.7M | $16.8M | $5.5M | $14.6M | $19.5M | $21.6M | $10.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$132.2M | $121.0M | $22.0M | $16.8M | -$175.7M | $202.0M | -$120.3M | $103.3M | $10.2M | ||
| Other Liabilities Noncurrent | $1.7M | $1.7M | $1.7M | $119.0K | $146.0K | $481.0K | $134.0K | $102.0K | $14.0K | ||
| Common Stock Value | $9.0K | $8.0K | $61.0K | $58.0K | $46.0K | $46.0K | $23.0K | $23.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $19.0K | $39.0K | $21.0K | -$618.0K | -$314.0K | $129.0K | $165.0K | -$47.0K | |||
| Contract With Customer Liability Noncurrent | $2.0M | $12.5M | $53.4M | $89.9M | $6.1M | $16.2M | $44.6M | $13.2M | |||
| Repayments Of Debt | $0.00 | $4.1M | $12.5M | $9.4M | $10.0M | $5.0M | |||||
| Long Term Debt Noncurrent | $0.00 | $3.8M | $15.7M | $24.5M | $8.9M | $10.0M | |||||
| Debt Current | $4.1M | $12.5M | $9.4M | $1.0M | $4.7M | $14.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$87.3M | -$32.1M | -$25.8M | $111.2M | $152.2M | $98.0M | $112.4M | $154.7M | $185.4M | $229.7M | $209.1M | $220.4M | $283.6M | $307.5M | $307.3M | $244.1M | $206.8M | $82.1M | $109.9M | $119.6M | $130.7M | -$141.4M | -$132.0M | -$120.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $66.8M | $64.9M | $107.1M | $175.4M | $91.6M | $66.1M | $82.7M | $236.0M | $63.3M | $97.7M | $80.0M | $29.8M | $31.6M | $57.3M | $56.7M | $65.2M | $65.4M | $43.6M | $12.0M | $19.4M | $26.6M | $41.4M | |||
| Restricted Cash Noncurrent | $858.0K | $858.0K | $858.0K | $857.0K | $857.0K | $857.0K | $872.0K | $872.0K | $872.0K | $872.0K | $872.0K | $872.0K | $872.0K | $872.0K | $872.0K | $872.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K |
| Cash And Cash Equivalents At Carrying Value | $65.9M | $64.0M | $106.2M | $174.6M | $90.8M | $65.2M | $81.8M | $235.1M | $62.5M | $96.8M | $79.1M | $28.9M | $30.7M | $56.4M | $55.8M | $64.4M | $65.3M | $43.6M | $12.0M | $19.4M | $26.6M | $41.4M | $25.4M | $6.6M | $25.4M |
| Accretion Amortization Of Discounts And Premiums Investments | $1.1M | $2.7M | $1.8M | -$546.0K | -$496.0K | $41.0K | $600.0K | $0.00 | |||||||||||||||||
| Equity Securities Fv Ni Unrealized Gain Loss | $0.00 | $0.00 | $0.00 | $4.8M | $3.7M | $694.0K | $8.3M | -$7.0M | $3.5M | -$3.7M | $563.0K | $4.5M | $4.3M | -$10.7M | $29.8M | $48.9M | |||||||||
| Retained Earnings Accumulated Deficit | -$931.2M | -$874.3M | -$862.8M | -$714.4M | -$665.6M | -$617.6M | -$590.5M | -$541.2M | -$502.7M | -$418.0M | -$398.5M | -$372.5M | -$295.3M | -$264.4M | -$258.2M | -$168.3M | -$185.5M | -$215.3M | -$181.0M | -$168.0M | -$154.3M | -$148.8M | |||
| Property Plant And Equipment Net | $13.3M | $15.0M | $16.8M | $19.0M | $19.4M | $20.6M | $22.3M | $23.6M | $24.0M | $24.3M | $23.6M | $23.3M | $23.3M | $18.7M | $14.8M | $11.9M | $11.3M | $9.5M | $8.5M | $9.3M | $9.9M | $11.7M | |||
| Prepaid Expense And Other Assets Current | $10.6M | $18.5M | $24.9M | $10.9M | $10.5M | $10.1M | $9.5M | $10.3M | $17.7M | $11.1M | $8.2M | $7.9M | $8.7M | $9.8M | $7.5M | $3.6M | $2.9M | $3.0M | $2.9M | $2.6M | $2.6M | $2.0M | |||
| Other Assets Noncurrent | $0.00 | $50.0K | $85.0K | $7.2M | $5.0M | $5.7M | $3.3M | $3.3M | $3.3M | $1.9M | $1.9M | $1.7M | $2.1M | $2.6M | $2.2M | $2.1M | $2.1M | $2.7M | $2.4M | $2.2M | $2.2M | $6.0M | |||
| Liabilities Current | $71.9M | $74.2M | $133.0M | $131.3M | $130.0M | $79.5M | $73.6M | $67.1M | $59.5M | $58.3M | $44.6M | $38.8M | $35.5M | $26.1M | $22.7M | $29.9M | $35.5M | $32.0M | $35.9M | $36.1M | $31.1M | $36.9M | |||
| Liabilities And Stockholders Equity | $209.7M | $262.4M | $321.4M | $451.8M | $489.0M | $403.4M | $431.7M | $464.9M | $358.0M | $400.7M | $385.6M | $303.7M | $371.5M | $359.8M | $358.5M | $307.2M | $277.5M | $153.9M | $171.7M | $188.8M | $202.5M | $145.0M | |||
| Liabilities | $296.9M | $294.5M | $347.2M | $340.6M | $336.9M | $305.4M | $319.4M | $310.2M | $172.6M | $171.0M | $176.6M | $83.3M | $87.9M | $52.3M | $51.2M | $63.1M | $70.8M | $71.8M | $61.8M | $69.3M | $71.7M | $99.2M | |||
| Assets Current | $182.1M | $231.6M | $287.4M | $405.8M | $443.5M | $354.6M | $381.3M | $412.0M | $304.1M | $346.6M | $331.5M | $228.7M | $250.7M | $277.6M | $266.0M | $292.3M | $258.5M | $127.5M | $135.6M | $162.2M | $176.5M | $127.4M | |||
| Assets | $209.7M | $262.4M | $321.4M | $451.8M | $489.0M | $403.4M | $431.7M | $464.9M | $358.0M | $400.7M | $385.6M | $303.7M | $371.5M | $359.8M | $358.5M | $307.2M | $277.5M | $153.9M | $171.7M | $188.8M | $202.5M | $145.0M | |||
| Additional Paid In Capital Common Stock | $843.8M | $842.2M | $837.0M | $825.5M | $817.9M | $715.7M | $702.8M | $695.8M | $688.1M | $649.0M | $608.9M | $594.0M | $578.9M | $571.9M | $565.5M | $412.2M | $391.8M | $297.4M | $290.6M | $287.4M | $284.9M | $7.4M | |||
| Accrued Liabilities Current | $13.2M | $11.8M | $11.6M | $13.2M | $9.9M | $7.1M | $11.4M | $9.5M | $6.4M | $10.4M | $7.7M | $5.4M | $8.5M | $6.5M | $4.5M | $5.9M | $4.5M | $2.9M | $4.6M | $3.6M | $2.5M | $4.1M | |||
| Accounts Receivable Net Current | $3.9M | $8.0M | $13.6M | $6.7M | $7.0M | $31.3M | $16.6M | $10.0M | $9.9M | $11.2M | $97.7M | $11.7M | $12.3M | $9.2M | $7.2M | $7.5M | $5.1M | $9.1M | $7.5M | $6.5M | $3.3M | $2.4M | |||
| Accounts Payable Current | $7.0M | $4.3M | $8.2M | $6.2M | $6.1M | $7.5M | $5.5M | $3.9M | $5.1M | $12.4M | $12.6M | $10.7M | $11.2M | $7.6M | $5.9M | $4.9M | $4.9M | $5.8M | $4.5M | $4.5M | $3.4M | $4.6M | |||
| Marketable Securities Current | $101.7M | $141.1M | $142.7M | $213.7M | $284.8M | $202.4M | $239.3M | $123.2M | $189.0M | $190.6M | $112.5M | $142.5M | $159.2M | $167.0M | $164.5M | $138.0M | $136.0M | $71.8M | $113.2M | $133.8M | $144.0M | $81.6M | |||
| Contract With Customer Liability Current | $9.0M | $12.0M | $69.0M | $72.6M | $74.0M | $20.5M | $24.0M | $18.0M | $17.2M | $15.9M | $6.5M | $6.3M | $7.8M | $8.1M | $12.1M | $15.7M | $23.5M | $22.9M | $20.3M | $21.4M | $19.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$84.1M | -$4.1M | $15.2M | -$1.5M | -$150.3M | $38.6M | -$98.7M | ||||||||||||||||||
| Other Liabilities Noncurrent | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $133.0K | $142.0K | $147.0K | $1.5M | $844.0K | $638.0K | $151.0K | $148.0K | $141.0K | $129.0K | $125.0K | $121.0K | $664.0K | ||||||
| Common Stock Value | $85.0K | $85.0K | $84.0K | $82.0K | $82.0K | $62.0K | $61.0K | $60.0K | $60.0K | $55.0K | $49.0K | $47.0K | $46.0K | $46.0K | $46.0K | $38.0K | $36.0K | $23.0K | $23.0K | $23.0K | $23.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $33.0K | -$13.0K | -$9.0K | $106.0K | -$163.0K | -$113.0K | $7.0K | $16.0K | -$107.0K | -$1.3M | -$1.4M | -$1.2M | -$30.0K | -$45.0K | $237.0K | $398.0K | $28.0K | $223.0K | $213.0K | $56.0K | -$27.0K | ||||
| Contract With Customer Liability Noncurrent | $3.8M | $6.9M | $8.6M | $18.0M | $21.7M | $46.3M | $78.2M | $79.9M | $85.0M | $74.7M | $90.0M | $145.0K | $193.0K | $822.0K | $8.4M | $10.6M | $15.1M | $19.8M | $25.6M | $31.5M | |||||
| Repayments Of Debt | $0.00 | $4.1M | $3.1M | $10.0M | $500.0K | $0.00 | |||||||||||||||||||
| Long Term Debt Noncurrent | $6.8M | $9.8M | $12.8M | $18.7M | $21.7M | $24.7M | $24.4M | $24.3M | $24.2M | $5.5M | $7.0M | $8.5M | $11.5M | ||||||||||||
| Debt Current | $7.1M | $10.2M | $13.2M | $12.5M | $12.5M | $12.5M | $6.3M | $3.1M | $5.8M | $5.8M | $5.8M | $3.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments Related To Tax Withholding For Share Based Compensation | $332.0K | $509.0K | $490.0K | $463.0K | $987.0K | $314.0K | $297.0K | |||
| Share Based Compensation | $14.0M | $24.7M | $24.9M | $26.3M | $23.2M | $11.9M | $10.3M | $2.9M | $1.4M | $968.0K |
| Proceeds From Maturities Of Marketable Securities | $253.8M | $538.9M | $435.0M | $128.0M | $148.3M | $116.4M | $128.6M | $2.8M | $34.9M | $57.8M |
| Payments To Acquire Marketable Securities | $265.0M | $461.5M | $460.3M | $216.7M | $248.7M | $130.7M | $196.2M | $81.5M | $14.2M | $52.3M |
| Net Cash Provided By Used In Operating Activities | -$177.2M | -$191.5M | -$111.6M | $3.5M | -$81.7M | -$67.8M | -$65.0M | $12.7M | -$37.1M | -$13.2M |
| Net Cash Provided By Used In Investing Activities | $45.0M | $218.5M | -$3.9M | -$35.0M | -$97.3M | $604.0K | -$51.1M | -$80.2M | $32.6M | $9.6M |
| Net Cash Provided By Used In Financing Activities | $44.0K | $94.1M | $137.6M | $48.3M | $3.3M | $269.2M | -$4.2M | $170.8M | $14.6M | $177.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$19.4M | $11.6M | -$109.0K | $3.5M | $4.0M | $80.0K | $1.4M | $2.2M | $354.0K | $371.0K |
| Increase Decrease In Employee Related Liabilities | $1.7M | -$1.8M | $1.5M | $1.7M | $2.6M | $2.8M | -$200.0K | $2.6M | $451.0K | $1.2M |
| Increase Decrease In Accounts Receivable | -$4.6M | -$27.5M | $29.0M | -$5.3M | $6.9M | -$739.0K | $3.8M | $865.0K | $1.0M | $171.0K |
| Depreciation Depletion And Amortization | $7.3M | $7.2M | $6.8M | $5.7M | $4.8M | $4.3M | $4.8M | $4.5M | $5.0M | $5.7M |
| Proceeds From Sales Of Marketable Securities | $57.9M | $70.2M | $25.7M | $32.8M | $18.5M | $22.0M | $20.0M | $0.00 | $15.2M | $8.5M |
| Increase Decrease In Contract With Customer Liability | -$69.7M | $7.8M | -$32.6M | $93.6M | -$15.2M | -$15.0M | -$20.2M | $42.3M | -$25.6M | -$23.1M |
| Increase Decrease In Accounts Payable | -$2.5M | $706.0K | $4.8M | -$1.2M | $2.7M | -$1.1M | $2.3M | $209.0K | -$473.0K | $874.0K |
| Proceeds From Stock Options Exercised | $4.0K | $271.0K | $314.0K | $268.0K | $2.5M | $1.9M | $180.0K | $134.0K | ||
| Proceeds From Stock Plans | $372.0K | $1.8M | $2.1M | $1.6M | $1.8M | $1.3M | $1.3M | |||
| Payments To Acquire Equipment And Leasehold Improvements | $1.7M | $3.1M | $4.3M | $7.9M | $15.3M | $7.1M | $3.5M | $1.6M | $3.3M | |
| Payments Related To Tax Withholding For Share Based Compensation | $332.0K | $509.0K | $490.0K | $463.0K | $987.0K | $314.0K | $297.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q3 2019 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments Related To Tax Withholding For Share Based Compensation | $25.0K | $61.0K | $180.0K | $74.0K | $37.0K | $374.0K | $33.0K | $6.0K | $451.0K | $50.0K | $9.0K | $404.0K | $580.0K | $407.0K | $314.0K | $297.0K | |||
| Share Based Compensation | $5.5M | $6.1M | $6.0M | $7.0M | $4.0M | $2.7M | $2.3M | $264.0K | |||||||||||
| Proceeds From Maturities Of Marketable Securities | $105.8M | $199.3M | $112.1M | $28.1M | $40.3M | $37.5M | $37.8M | $0.00 | |||||||||||
| Payments To Acquire Marketable Securities | $142.4M | $135.0M | $52.8M | $11.0M | $164.6M | $3.6M | $119.1M | $0.00 | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$67.9M | -$64.7M | -$61.0M | -$35.3M | -$30.4M | -$18.7M | -$20.1M | -$15.0M | |||||||||||
| Net Cash Provided By Used In Investing Activities | -$16.3M | $64.1M | $67.5M | $33.0M | -$121.7M | $41.6M | -$78.1M | -$364.0K | |||||||||||
| Net Cash Provided By Used In Financing Activities | $66.0K | -$3.4M | $8.8M | $760.0K | $1.8M | $15.7M | -$458.0K | -$14.0K | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$11.0K | $2.4M | $7.4M | -$212.0K | $3.4M | -$1.4M | -$336.0K | $130.0K | |||||||||||
| Increase Decrease In Employee Related Liabilities | -$1.4M | -$7.6M | -$6.8M | -$6.0M | -$4.3M | -$3.1M | -$3.7M | $980.0K | |||||||||||
| Increase Decrease In Accounts Receivable | $4.9M | -$4.8M | $2.8M | -$768.0K | $1.7M | $2.8M | $849.0K | $2.5M | |||||||||||
| Depreciation Depletion And Amortization | $1.9M | $1.8M | $1.6M | $1.3M | $1.3M | $1.1M | $1.1M | $1.2M | |||||||||||
| Proceeds From Sales Of Marketable Securities | $21.5M | $290.0K | $9.1M | $17.4M | $5.0M | $8.5M | $3.5M | $0.00 | |||||||||||
| Increase Decrease In Contract With Customer Liability | -$4.8M | -$7.2M | -$4.4M | $783.0K | -$7.8M | $2.3M | -$5.3M | -$2.7M | |||||||||||
| Increase Decrease In Accounts Payable | -$1.9M | -$1.9M | $198.0K | -$1.1M | -$462.0K | $476.0K | -$189.0K | ||||||||||||
| Proceeds From Stock Options Exercised | $0.00 | $117.0K | $314.0K | $180.0K | $1.4M | $56.0K | $42.0K | $38.0K | |||||||||||
| Proceeds From Stock Plans | $246.0K | $911.0K | $1.1M | $1.0M | $873.0K | $646.0K | |||||||||||||
| Payments To Acquire Equipment And Leasehold Improvements | $1.2M | $446.0K | $942.0K | $1.6M | $2.4M | $763.0K | |||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $180.0K | $374.0K | $451.0K | $404.0K | $407.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$22.49 | -$29.40 | -$1.78 | -$2.35 | -$2.29 | -$0.99 | -$2.43 | -$6.13 | -$43.95 | $0.00 |
| Earnings Per Share Basic | $-22.49 | $-29.40 | $-1.78 | $-2.35 | $-2.29 | $-0.99 | ||||
| Common Stock Shares Outstanding | 8.6M | 8.3M | 61.0M | 57.5M | 46.3M | 45.8M | 23.1M | 22.8M | 465.3K | |
| Common Stock Shares Issued | 8.6M | 8.3M | 61.0M | 57.5M | 46.3M | 45.8M | 23.1M | 22.8M | 465.3K | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 271.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 8.5M | 7.7M | 60.2M | 50.7M | 46.1M | 32.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 8.5M | 7.7M | 60.2M | 50.7M | 46.1M | 32.6M | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.67 | -$0.14 | -$0.91 | -$0.59 | -$0.59 | -$0.59 | -$0.81 | -$0.64 | -$0.85 | -$0.37 | -$0.55 | -$0.84 | -$0.67 | -$0.13 | -$0.66 | $0.45 | $0.94 | -$0.84 | -$0.65 | -$0.56 | -$0.60 | -$0.62 | -$0.07 | -$21.26 | -$24.17 | -$25.76 | -$33.51 | -$3.14 | -$4.07 | -$2.55 |
| Earnings Per Share Basic | $-0.67 | $-0.14 | $-0.91 | $-0.59 | $-0.59 | $-0.59 | $-0.81 | $-0.64 | $-0.85 | $-0.37 | $-0.55 | $-0.84 | $-0.67 | $-0.13 | $0.46 | $1.00 | $-0.56 | $-0.60 | ||||||||||||
| Common Stock Shares Outstanding | 85.1M | 84.7M | 84.3M | 82.4M | 81.9M | 62.5M | 60.9M | 60.5M | 60.2M | 54.6M | 48.7M | 46.9M | 46.3M | 46.1M | 46.1M | 38.1M | 35.9M | 23.2M | 23.1M | 22.9M | 22.9M | 485.1K | ||||||||
| Common Stock Shares Issued | 85.1M | 84.7M | 84.3M | 82.4M | 81.9M | 62.5M | 60.9M | 60.5M | 60.2M | 54.6M | 48.7M | 46.9M | 46.3M | 46.1M | 46.1M | 38.1M | 35.9M | 23.2M | 23.1M | 22.9M | 22.9M | 485.1K | ||||||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 818.0M | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 84.9M | 84.6M | 83.1M | 82.0M | 81.2M | 61.5M | 60.6M | 60.3M | 58.7M | 52.3M | 47.0M | 46.5M | 46.2M | 46.1M | 36.9M | 29.9M | ||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 84.9M | 84.6M | 83.1M | 82.0M | 81.2M | 61.5M | 60.6M | 60.3M | 58.7M | 52.3M | 47.0M | 46.5M | 46.2M | 46.1M | 37.9M | 31.8M | ||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $14.0M | $24.7M | $24.9M | $26.3M | $23.2M | $11.9M | $10.3M | $2.9M | $1.4M | $968.0K |
| Stock Issued During Period Value Stock Options Exercised | $4.0K | $271.0K | $314.0K | $268.0K | $1.9M | $180.0K | $95.0K | $184.0K | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $372.0K | $1.8M | $2.1M | $1.6M | $1.8M | $1.3M | $1.3M | |||
| Other Noncash Income Expense | -$571.0K | -$766.0K | -$622.0K | -$324.0K | -$1.2M | -$587.0K | -$468.0K | -$337.0K | -$103.0K | -$98.0K |
| Interest Paid Net | $0.00 | $310.0K | $1.1M | $1.9M | $2.0M | $1.7M | $1.0M | $1.3M | $479.0K | $0.00 |
| Capital Expenditures Incurred But Not Yet Paid | $11.0K | $673.0K | $214.0K | $280.0K | $370.0K | $546.0K | $270.0K | $205.0K | $255.0K | $532.0K |
| Interest And Other Income Expense Net | -$3.9M | $25.8M | -$11.2M | -$3.3M | -$3.1M | -$4.0M | -$4.4M | $290.0K | -$689.0K | |
| Interest And Other Expense Net | $3.1M | $4.1M | $4.4M | -$290.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.6M | $5.3M | $5.5M | $6.5M | $6.2M | $6.1M | $6.0M | $6.7M | $6.0M | $6.8M | $6.7M | $7.0M | $6.5M | $5.9M | $4.0M | $3.1M | $3.0M | $2.7M | $2.9M | $2.5M | $2.3M | $321.0K | $232.0K | $249.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $154.0K | $117.0K | $314.0K | $85.0K | $2.0K | $180.0K | $160.0K | $452.0K | $1.4M | $108.0K | $8.0K | $56.0K | $81.0K | $10.0K | $42.0K | $36.0K | $38.0K | ||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $126.0K | $246.0K | $937.0K | $911.0K | $954.0K | $1.1M | $607.0K | $1.0M | $892.0K | $873.0K | $639.0K | $646.0K | $589.0K | $671.0K | ||||||||||
| Other Noncash Income Expense | -$168.0K | -$189.0K | $13.0K | -$125.0K | -$39.0K | $19.0K | -$73.0K | -$35.0K | ||||||||||||||||
| Interest Paid Net | $0.00 | $63.0K | $393.0K | $504.0K | $331.0K | $134.0K | $330.0K | $300.0K | ||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $27.0K | $219.0K | $371.0K | $881.0K | $809.0K | $255.0K | $63.0K | $5.0K | ||||||||||||||||
| Interest And Other Income Expense Net | -$737.0K | -$1.0M | -$1.3M | $22.2M | -$1.8M | -$2.2M | -$2.7M | -$2.9M | -$3.0M | -$2.8M | -$594.0K | -$657.0K | -$1.1M | -$1.2M | ||||||||||
| Interest And Other Expense Net | $2.8M | $594.0K | $657.0K | $820.0K | $847.0K | $858.0K | $2.3M | $3.0M | $1.1M | $1.1M | $1.2M | $1.2M | $483.0K | -$507.0K | $383.0K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.